For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0 | -4,229 | 0 | 1,916 |
| Cost of goods sold | 70 | -4,038 | 27 | 2,147 |
| Gross profit (loss) | -70 | -191 | -27 | -231 |
| Sales and marketing | 0 | - | 0 | 1,383 |
| Research and product development | 0 | - | 0 | 1,359 |
| General and administrative | 780 | -1,120 | 827 | 1,586 |
| Legal expense | - | 62* | - | - |
| Professional fees | - | -2,996* | - | - |
| Total operating expenses | 780 | -4,054 | 827 | 4,328 |
| Operating gain | -850 | 3,863 | -854 | -4,559 |
| Interest income (expense), net | - | 0 | - | - |
| Interest (expense) | 0 | - | 20 | 8 |
| Other income, net | 0 | -136 | 4 | 3 |
| Gain from continuing operations before income taxes | -850 | 3,727 | -870 | -4,564 |
| Provision for income taxes | 0 | 5,738 | 1 | 8 |
| Loss from continuing operations | -850 | -2,011* | -871 | - |
| Revenue | - | 1,502* | - | - |
| Cost of goods sold | - | 2,257* | - | - |
| Gross profit (loss) | - | -755* | - | - |
| Operating expenses | - | 1,824* | - | - |
| Operating loss | - | -2,579* | - | - |
| Loss on sale | - | -352* | - | - |
| Loss before income taxes | - | -2,931* | - | - |
| Income tax benefit (provision) | - | 0* | - | - |
| Income (gain) from discontinued operations, net of tax | 363 | -2,931* | -12,865 | - |
| Net loss | -487 | -4,942 | -13,736 | -4,572 |
| Unrealized gain on available-for-sale securities, net of tax | - | - | 0 | 0 |
| Unrealized gain (loss) on available-for-sale securities, net of tax | - | 0 | - | - |
| Change in foreign currency translation adjustment | -10 | -5 | -6 | -10 |
| Comprehensive loss | -497 | -4,947 | -13,742 | -4,582 |
| Basic EPS | -0.21 | -2.802 | -7.92 | -2.64 |
| Diluted EPS | -0.18 | -2.802 | -7.92 | -2.64 |
| Basic Average Shares | 2,383,745 | 1,765,654* | 1,734,250 | 1,733,307 |
| Diluted Average Shares | 2,754,160 | 1,765,654* | 1,734,250 | 1,733,307 |